Abstract
ANGIOTENSIN II is an important effector molecule controlling blood pressure and volume in the cardiovascular system1. Its importance is manifested by the efficacy of angiotensin-converting enzyme inhibitors in the treatment of hypertension and congestive heart failure2,3. Angiotensin II interacts with two pharmacologi-cally distinct subtypes of cell-surface receptors, AT1 and AT2 (ref. 4). AT1 receptors seem to mediate the major cardiovascular effects of angiotensin II5,6. Here we report the isolation by expression cloning of a complementary DNA encoding a unique protein with the pharmacological specificity of a vascular AT1 receptor. Hydropathic modelling of the deduced protein suggests that it shares the seven-transmembrane-region motif with the G protein-coupled receptor superfamily7. Knowledge of the AT1 receptor primary sequence should now permit structural analysis, definition of the angiotensin II receptor gene family and delineation of the contribution of AT receptors to the genetic component of hypertension.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Peach, M. J. Physiol. Rev. 57, 313–370 (1977).
Bauer, J. H. Am. J. Med. 77 (Suppl. 2A), 43–51 (1984).
Davis, R., Ribner, H. S., Keung, E., Sonnenblick, E. H. & LeJemtel, T. H. New Engl. J. Med. 301, 117–121 (1979).
Bumpus, F. M. et al. Hypertension (in the press).
Wong, P. C. et al. J. Pharmac. exp. Ther. 255, 584–592 (1990).
Dudley, D. T. et al. Molec. Pharmac. 38, 370–377 (1990).
Dohlman, H. G., Caron, M. C. & Lefkowitz, R. J. Biochemistry 26, 2657–2664 (1987).
Wong, G. C. et al. Science 228, 810–815 (1985).
Seed, B. & Aruffo, A. Proc. natn. Acad. Sci. U.S.A. 84, 3365–3369 (1987).
Socorro, L., Alexander, R. W. & Griendling, K. K. Biochem. J. 265, 799–807 (1990).
Douglas, J. G. Am. J. Physiol. 253, F1–F7 (1987).
Chiu, A. T. et al. J. Pharmac. exp. Ther. 250, 867–874 (1989).
Chang, R. S. L. & Lotti, V. J. Molec. Pharmac. 29, 347–351 (1990).
Chiu, A. T. et al. Eur. J. Pharmac. 170, 117–118 (1989).
Griendling, K. K. et al. J. biol. Chem. 261, 5901–5906 (1986).
Kozak, M. Cell 44, 283–292 (1986).
Escher, E. Pharmac. Ther. 37, 37–55 (1988).
Karnik, S. S., Sakmar, T. P., Chen, H.-A. & Khorana, G. Proc. natn. Acad. Sci. U.S.A. 85, 8459–8463 (1988).
McFarland, K. C. et al. Science 245, 494–499 (1989).
Yokota, Y. et al. J. biol. Chem. 264, 17649–17652 (1989).
Arai, H., Hori, S., Aramori, I., Ohkubo, H. & Nakanishi, S. Nature 348, 730–732 (1990).
Sakurai, T. et al. Nature 348, 732–735 (1990).
Kemp, B. E. & Pearson, R. B. Trends Biochem. 15, 342–346 (1990).
Capponi, A. M., Aguilera, G., Fakunding, J. L. & Catt, K. J. in Biochemical Regulation in Blood Pressure (ed. Soffer, R. L.) 205–262 (Wiley, New York, 1981).
Jackson, T. R., Blair, L. A. C., Marshall, J., Goedert, M. & Hanley, M. R. Nature 335, 437–440 (1988).
Bouscarel, B., Blackmore, P. F. & Exton, J. H. J. biol. Chem. 263, 14913–14919 (1988).
Phillips, M. I. A. Rev. Physiol. 49, 413–435 (1987).
Millan, N. A. et al. Science 244, 1340–1342 (1989).
Murphy, T. J. & Bylund, D. B. J. Pharmac. exp. Ther. 244, 571–578 (1988).
Chen, C. A. & Okayama, H. Biotechniques 6, 632–638 (1988).
Alexander, R. W., Brock, T. A., Gimbrone, M. A. & Rittenhouse, S. E. Hypertension 7, 447–451 (1985).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Murphy, T., Alexander, R., Griendling, K. et al. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature 351, 233–236 (1991). https://doi.org/10.1038/351233a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/351233a0
This article is cited by
-
The Renin Angiotensin System as a Therapeutic Target in Traumatic Brain Injury
Neurotherapeutics (2023)
-
DAD3 targets ACE2 to inhibit the MAPK and NF-κB signalling pathways and protect against LPS-induced inflammation in bovine mammary epithelial cells
Veterinary Research (2022)
-
A historical perspective on ACE2 in the COVID-19 era
Journal of Human Hypertension (2021)
-
2020 update on the renin–angiotensin–aldosterone system in pediatric kidney disease and its interactions with coronavirus
Pediatric Nephrology (2021)
-
Probing the structural requirements for angiotensin II receptor: molecular modeling studies
Network Modeling Analysis in Health Informatics and Bioinformatics (2018)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.